654 related articles for article (PubMed ID: 21091684)
21. Hidradenitis suppurativa managed with adalimumab.
Yamauchi PS; Mau N
J Drugs Dermatol; 2009 Feb; 8(2):181-3. PubMed ID: 19213236
[TBL] [Abstract][Full Text] [Related]
22. A prospective open-label clinical trial of adalimumab for the treatment of hidradenitis suppurativa.
Amano M; Grant A; Kerdel FA
Int J Dermatol; 2010 Aug; 49(8):950-5. PubMed ID: 21128923
[TBL] [Abstract][Full Text] [Related]
23. New-onset polyarthritis during successful treatment of hidradenitis suppurativa with infliximab.
van Rappard DC; Mooij JE; Baeten DL; Mekkes JR
Br J Dermatol; 2011 Jul; 165(1):194-8. PubMed ID: 21428974
[TBL] [Abstract][Full Text] [Related]
24. Adalimumab (antitumour necrosis factor-α) treatment of hidradenitis suppurativa ameliorates skin inflammation: an in situ and ex vivo study.
van der Zee HH; Laman JD; de Ruiter L; Dik WA; Prens EP
Br J Dermatol; 2012 Feb; 166(2):298-305. PubMed ID: 22013960
[TBL] [Abstract][Full Text] [Related]
25. The cutting edge. Severe hidradenitis suppurativa treated with adalimumab.
Moul DK; Korman NJ
Arch Dermatol; 2006 Sep; 142(9):1110-2. PubMed ID: 16982997
[No Abstract] [Full Text] [Related]
26. Treatment of hidradenitis suppurativa with tumour necrosis factor-alpha inhibitors.
Haslund P; Lee RA; Jemec GB
Acta Derm Venereol; 2009 Nov; 89(6):595-600. PubMed ID: 19997689
[TBL] [Abstract][Full Text] [Related]
27. Hidradenitis suppurativa responding to treatment with infliximab.
Lasocki A; Sinclair R; Foley P; Saunders H
Australas J Dermatol; 2010 Aug; 51(3):186-90. PubMed ID: 20695857
[TBL] [Abstract][Full Text] [Related]
28. Current and emerging nonsurgical treatment options for hidradenitis suppurativa.
Kerdel FA
Semin Cutan Med Surg; 2014 Jun; 33(3 Suppl):S57-9. PubMed ID: 25188460
[TBL] [Abstract][Full Text] [Related]
29. Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: a randomized, double-blind, placebo-controlled crossover trial.
Grant A; Gonzalez T; Montgomery MO; Cardenas V; Kerdel FA
J Am Acad Dermatol; 2010 Feb; 62(2):205-17. PubMed ID: 20115947
[TBL] [Abstract][Full Text] [Related]
30. Hidradenitis suppurativa: A practical review of possible medical treatments based on over 350 hidradenitis patients.
Scheinfeld N
Dermatol Online J; 2013 Apr; 19(4):1. PubMed ID: 24021361
[TBL] [Abstract][Full Text] [Related]
31. Management of patients with hidradenitis suppurativa.
Martorell A; Caballero A; González Lama Y; Jiménez-Gallo D; Lázaro Serrano M; Miranda J; Pascual JC; Salgado-Boquete L; Marín-Jiménez I
Actas Dermosifiliogr; 2016 Sep; 107 Suppl 2():32-42. PubMed ID: 28081768
[TBL] [Abstract][Full Text] [Related]
32. Sustained clinical response in psoriatic arthritis patients treated with anti-TNF agents: a 5-year open-label observational cohort study.
Saougou I; Markatseli TE; Papagoras C; Voulgari PV; Alamanos Y; Drosos AA
Semin Arthritis Rheum; 2011 Apr; 40(5):398-406. PubMed ID: 20843542
[TBL] [Abstract][Full Text] [Related]
33. [Treatment options in severe hidradenitis suppurativa].
Mooij JE; van't Oost L; Leenarts MF; Mekkes JR
Ned Tijdschr Geneeskd; 2011; 155():A1912. PubMed ID: 21426594
[TBL] [Abstract][Full Text] [Related]
34. An open-label phase II study of the safety and efficacy of etanercept for the therapy of hidradenitis suppurativa.
Giamarellos-Bourboulis EJ; Pelekanou E; Antonopoulou A; Petropoulou H; Baziaka F; Karagianni V; Stavrianeas N; Giamarellou H
Br J Dermatol; 2008 Mar; 158(3):567-72. PubMed ID: 18076705
[TBL] [Abstract][Full Text] [Related]
35. Treatment of hidradenitis suppurativa with infliximab in a patient with Crohn's disease.
Rosi YL; Lowe L; Kang S
J Dermatolog Treat; 2005 Feb; 16(1):58-61. PubMed ID: 15897171
[TBL] [Abstract][Full Text] [Related]
36. Hidradenitis suppurativa (acne inversa): management of a recalcitrant disease.
Lam J; Krakowski AC; Friedlander SF
Pediatr Dermatol; 2007; 24(5):465-73. PubMed ID: 17958790
[TBL] [Abstract][Full Text] [Related]
37. Differential effectiveness of etanercept and infliximab in the treatment of ocular inflammation.
Galor A; Perez VL; Hammel JP; Lowder CY
Ophthalmology; 2006 Dec; 113(12):2317-23. PubMed ID: 16996615
[TBL] [Abstract][Full Text] [Related]
38. Moderate to severe hidradenitis suppurativa treated with biological therapies.
Chinniah N; Cains GD
Australas J Dermatol; 2014 May; 55(2):128-31. PubMed ID: 24456051
[TBL] [Abstract][Full Text] [Related]
39. Adalimumab treatment for hidradenitis suppurativa associated with Crohn's disease.
Diamantova D; Lomickova I; Cetkovska P
Acta Dermatovenerol Croat; 2014; 22(4):291-3. PubMed ID: 25580790
[TBL] [Abstract][Full Text] [Related]
40. [Hidradenitis suppurativa].
Tolaas E; Knudsen CW; Sviland L; Tønseth KA
Tidsskr Nor Laegeforen; 2009 May; 129(10):992-6. PubMed ID: 19448752
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
